SEARCH

SEARCH BY CITATION

References

  • 1
    DeJongh FE, Janssen HLA, DeMan LA, Hop WCJ, Schalm SW, Van Blankenstein M. Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver. Gastroenterology 1992; 103:16301635.MEDLINE
  • 2
    Nevens F, Goubau P, Van Eyken P, Desmyter J, Desmet V, Fevery J. Treatment of decompensated viral hepatitis B-induced cirrhosis with low doses of interferon alpha. Liver 1993; 13:1519.MEDLINE
  • 3
    Hoofnagle JH, Di Bisceglie AM, Waggoner JG, Park Y. Interferon alpha for patients with clinically apparent cirrhosis due to chronic hepatitis B. Gastroenterology 1993; 104:11161121.MEDLINE
  • 4
    Perillo R, Tamburro C, Regenstein F, Bolart L, Bodenheimer H, Silva M, Schiff E, et al. Low-dose, titratable interferon alfa in decompensated liver disease caused by chronic infection with hepatitis B virus. Gastroenterology 1995; 109:908916.MEDLINE
  • 5
    Marcellin P, Giuily N, Loriot MA, Durand F, Samuel D, Bettan L, Degott C, et al. Prolonged interferon-alpha therapy of hepatitis B virus-related decompensated cirrhosis. J Viral Hepatitis 1997; 4(suppl 1):2126.
  • 6
    Dienstag JL, Perillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 1995; 333:16571661.MEDLINE
  • 7
    Nevens F, Main F, Honkoop P, Tyrrell DL, Barber J, Sullivan MT, Fevery J, et al. Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging study. Gastroenterology 1997; 113:12581263.MEDLINE
  • 8
    Lai CL, Chien RN, Leung NWY, Chang TT, Guan R, Tai DI, Ng KY, et al. A one-year trial of lamivudine for chronic hepatitis B. N Engl J Med 1998; 339:6168.MEDLINE
  • 9
    Perillo R, Rakela J, Martin P, Wright T, Levy G, Schiff E, Dienstag J, et al. Lamivudine for suppression and/or prevention of hepatitis B when given pre/post liver transplantation (OLT) [Abstract]. Hepatology 26:6168.
  • 10
    Van Thiel DH, Friedland L, Kania RJ, Molloy PJ, Hassaneim E, Faruki H. Lamivudine treatment of advanced and decompensated liver disease due to hepatitis B. Hepato-Gastroenterology 1997; 44:808812.
  • 11
    Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60:646649.MEDLINE
  • 12
    Melegari M, Scaglioni PP, Wands JR. Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective. Hepatology 1998; 27:628633.MEDLINE
  • 13
    Ono-Nita SK, Kato N, Shiratori Y, Lan KH, Yoshida H, Kato J, Carilloho FJ, et al. Susceptibility of lamivudine resistant hepatitis B virus to other antivirals: adefovir and lobucavir. Hepatology 1998; 28:165A.